Supports capital-efficient expansion of the SLS009 clinical program into frontline AML, enabling broader U.S. and European patient enrollment U.S. enrollment evaluating SLS009 in combination with ...
Nova Minerals Limited ("Nova" or the "Company") (NASDAQ: NVA) (ASX: NVA) (FRA: QM3)) is pleased to announce further drill ...
Premier American Uranium Inc. ('PUR”, the 'Company” or 'Premier American Uranium”) (TSXV: PUR) (OTCQB: PAUIF) is pleased to announce completion of the 2025 exploration drilling program at the Cyclone ...
Premier American Uranium Inc. ("PUR", the "Company" or "Premier American Uranium"- (TSXV: PUR) (OTCQB: PAUIF) is pleased to ...
As previously disclosed, the studies did not meet pre-specified co-primary, secondary, or exploratory biomarker endpoints The paper provides a detailed analysis of the RETHINK-ALZ and REFOCUS-ALZ ...